Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms - Trial NCT06409338
Access comprehensive clinical trial information for NCT06409338 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital with Nanjing Medical University and is currently Not yet recruiting. The study focuses on Parkinson Disease. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The First Affiliated Hospital with Nanjing Medical University
Timeline & Enrollment
N/A
May 01, 2024
Sep 01, 2024
Primary Outcome
alterations in functional topological properties within the cortex of bilateral cerebral hemispheres-Sigma,alterations in functional topological properties within the cortex of bilateral cerebral hemispheres-global efficiency (Eg),alterations in functional topological properties within the cortex of bilateral cerebral hemispheres-local efficiency (Eloc),alterations in functional topological properties within the cortex of bilateral cerebral hemispheres-nodal efficiency (Ne),changes in MEPs values,changes in RMT values,changes in CSP values,changes in SICI values,changes in ICF values
Summary
This study is a double blind comparative study exploring the neural underpinnings of taVNS
 modulating PD motor deficits. We hypothesize that taVNS might improve PD motor deficits by
 regulating the balance between excitation and inhibition in the primary motor cortex.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06409338
Device Trial